New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 21, 2013
10:10 EDTPICO, TTI, WEN, FNSR, JDSU, MRC, CXO, HURN, BKW, VIPS, SGYP, SCMP, ICPT, IRWD, PTN, MKGAY, REGI, IT, XOM, DAR, CVX, AMRNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Amarin (AMRN) initiated with a Perform at Oppenheimer... Chevron (CVX) initiated with an Outperform at Wells Fargo... Darling (DAR) initiated with an Outperform at Wedbush... Exxon Mobil (XOM) initiated with a Market Perform at Wells Fargo... Gartner (IT) initiated with a Buy at Stifel... Intercept (ICPT) initiated with an Outperform at Oppenheimer... Ironwood (IRWD) initiated with an Outperform at Credit Suisse... Merck KGaA (MKGAY) initiated with a Sell at Goldman... Palatin Tech (PTN) initiated with an Overweight at Piper Jaffray... Renewable Energy (REGI) initiated with an Outperform at Wedbush... Sucampo (SCMP) initiated with a Neutral at Credit Suisse... Synergy Pharmaceuticals (SGYP) initiated with an Outperform at Credit Suisse... Tetra Technologies (TTI) initiated with an Equal Weight at Stephens... Wendy's (WEN) initiated with a Market Perform at Wells Fargo... Finisar (FNSR) initiated with a Buy at Craig-Hallum... JDSU (JDSU) initiated with a Buy at Craig-Hallum... MRC Global (MRC) initiated with a Buy at Maxim... Concho Resources (CXO) re-initiated with a Buy at BofA/Merrill... Huron (HURN) initiated with a Buy at Stifel... Burger King (BKW) initiated with a Market Perform at Wells Fargo... PICO Holdings (PICO) initiated with an Outperform at Northland Securities... Vipshop (VIPS) initiated with a Buy at Citigroup.
News For AMRN;CVX;DAR;XOM;IT;ICPT;IRWD;PTN;MKGAY;REGI;SCMP;SGYP;TTI;WEN;FNSR;JDSU;MRC;CXO;HURN;BKW;VIPS;PICO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 13, 2014
07:15 EDTXOMNational Association of Corporate Directors to hold a conference
Subscribe for More Information
06:36 EDTCVX, XOMSaudi Arabia content to let oil prices stay low, Reuters reports
Subscribe for More Information
October 12, 2014
13:53 EDTXOM, CVXKuwaiti Minister says OPEC unlikely to cut production, WSJ says
Subscribe for More Information
13:45 EDTCVX, XOMSaudis take aggressive oil measures in Europe, WSJ says
Subscribe for More Information
October 10, 2014
18:17 EDTXOMExxon Mobil to receive less than $1B from Venezuelan government, Reuters says
Subscribe for More Information
10:01 EDTSCMPOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:01 EDTSCMPSucampo upgraded to Buy from Hold at Maxim
Subscribe for More Information
October 9, 2014
18:47 EDTSCMPOn The Fly: After Hours Movers
UP AFTER EARNINGS: Helen of Troy (HELE), up 3%... Barracuda Networks (CUDA), up marginally after reporting second quarter results. ALSO HIGHER: Sucampo Pharmaceuticals (SCMP), up 19.2% after announcing settlement agreement resolving patent litigation on AMITIZA... Civeo (CVEO), up 15% after Greenlight Capital reported a 9.99% stake in the company... EXCO Resources (XCO), up 10.6% after T. Boone Pickens says that company approached by buyers, reported by Bloomberg... EXACT Sciences (EXAS), up 3.7% after announcing final national coverage determination for Cologuard... US Ecology (ECOL), up 2.5% following announcement that it will replace Measurement Specialties (MEAS) in S&P 600. DOWN AFTER EARNINGS: Procera Networks (PKT), down 19.3%... Sizmek (SZMK), down 13.9% following third quarter revenue guidance... VOXX International (VOXX), down 12.5%... Knowles (KN), down 8.1% after lowering third quarter guidance... Microchip (MCHP), down 8.2% after lowering second quarter guidance... Juniper Networks (JNPR), down 3.6% after lowering third quarter outlook. ALSO LOWER: GT Advanced Technologies (GTAT), down 23.3% following a Bloomberg report that it will as to wind down sapphire operations.
16:49 EDTSCMPSucampo announces settlement agreement resolving patent litigation on AMITIZA
Subscribe for More Information
13:47 EDTXOMICSID: Venezuela must pay Exxon $1.6B for nationalizations
Subscribe for More Information
09:06 EDTCVXChevron names Francis Chief Governance Officer to succeed Beebe
Subscribe for More Information
09:04 EDTCVXChevron names Francis Chief Governance Officer
Subscribe for More Information
09:03 EDTICPTIntercept pullback a buying opportunity, says Summer Street
Subscribe for More Information
08:10 EDTVIPSVipshop announces ADS ratio change to 5 ADS to 1 ordinary share
Vipshop Holdings announced that it will change its ADS to Class A Ordinary Share ratio from one ADS representing two shares to five ADSs representing one Share, effective November 3. Vipshop ADS holders of record as of the close of business on October 31, 2014 will receive nine additional ADSs for every one ADS held on that date. For Vipshop's ADS holders, this ratio change will have the same effect as a 10-for-1 ADS split. The ADS ratio change will have no impact on Vipshop's underlying Shares. Furthermore, no action by ADS holders is required to effect the ratio change.
08:03 EDTCVXCBI joint venture with Chevron wins technology award in Bahrain
Chicago Bridge & Iron (CBI) and Chevron's (CVX) joint venture Chevron Lummus Global has been awarded a contract in excess of $100M by Bahrain Petroleum Co. The scope of work includes the license of its LC-Fining and Isocracking technologies and engineering design packages for the new residue hydrocracking and vacuum gasoil hydrocracking units for the Bapco Modernization Program.
October 8, 2014
16:56 EDTITGartner says worldwide PC shipments in Q3 declined 0.5%
Subscribe for More Information
12:42 EDTICPTIntercept weakness a buying opportunity, says Wedbush
Subscribe for More Information
12:11 EDTICPTIntercept management to meet with Oppenheimer
Subscribe for More Information
09:20 EDTICPTOn The Fly: Pre-market Movers
Subscribe for More Information
07:05 EDTICPTIntercept says FLINT trial NASH data will not be presented at AASLD
Intercept Pharmaceuticals announced upcoming presentations of data at the upcoming American Academy for the Study of Liver Diseases, or AASLD, Annual Meeting, being held in Boston, Massachusetts from November 7-11. Obeticholic acid, or OCA, Intercept's lead product candidate, is a bile acid analog and first-in-class agonist of the farnesoid X receptor in development for primary biliary cirrhosis, nonalcoholic steatohepatitis, primary sclerosing cholangitis and other chronic liver and intestinal diseases. CEO Mark Pruzanski said, "We are pleased that several key abstracts from Intercept's Phase 3 program for OCA in PBC will be presented at AASLD. With respect to the NIDDK-sponsored FLINT trial of OCA in NASH, we have learned that the NASH CRN has decided to focus on finalizing the manuscript intended for near term publication in lieu of presentation at AASLD. We are reaffirming the previously reported top-line results based on a revised draft manuscript that our partners at NIDDK have provided us. We believe that peer reviewed publication of the FLINT data will mark another important milestone supportive of OCA's potential as a novel therapy for patients with NASH and associated liver fibrosis. In the meantime, we continue preparing for the initiation of our Phase 3 NASH program in the first half of 2015."
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use